Comparative Effects of Mirror Therapy, Proprioceptive Neuromuscular Facilitation, and Constraint-Induced Movement Therapy on Upper Limb Motor Recovery in Stroke Survivors: A Three-Arm Randomized Controlled Trial

This study aimed to compare the effects of these three interventions on upper limb motor recovery in stroke survivors.

A three-arm randomized controlled trial was conducted in which eligible participants (N=90) with post-stroke upper limb hemiparesis were randomly allocated into three groups of 30 each: MT group, PNF group, and CIMT group. All groups received their respective interventions alongside conventional physiotherapy, five sessions per week for six weeks.

Study Overview

Detailed Description

Stroke remains a leading cause of long-term disability worldwide, with upper limb motor impairment being one of the most prevalent and debilitating consequences. While several neurorehabilitation approaches have demonstrated efficacy individually, limited evidence existed comparing the relative effectiveness of mirror therapy (MT), proprioceptive neuromuscular facilitation (PNF), and constraint-induced movement therapy (CIMT) within a single trial framework. This study aimed to compare the effects of these three interventions on upper limb motor recovery in stroke survivors.

A three-arm randomized controlled trial was conducted in which eligible participants (N=90) with post-stroke upper limb hemiparesis were randomly allocated into three groups of 30 each: MT group, PNF group, and CIMT group. All groups received their respective interventions alongside conventional physiotherapy, five sessions per week for six weeks. The outcome measure were the Fugl-Meyer Assessment for Upper Extremity (FMA-UE), Action Research Arm Test (ARAT), Modified Ashworth Scale (MAS) and grip strength via hand-held dynamometry. Assessments were performed at baseline and at after 12 weeks post-intervention.

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab Province
      • Gujrat, Punjab Province, Pakistan
        • Ikram Hospital, Gujrat

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Stroke Patients Both male and female Age: 25-65 years -

Exclusion Criteria:

unable to perform exercises Do not provide consent Cognitive Impairment

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Mirror Therapy
Mirror Therapy: Participant in the group were provided mirror therapy for a duration of 12 weeks
Active Comparator: Proprioceptive Neuromuscular Facilitation
PNF Group: Participant were given PNF therapy for a total duration of 12 weeks
Active Comparator: Constraint-Induced Movement Therapy
Constraint-induced movement therapy: Participant were given Constraint-induced movement therapy for a total duration of 12 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Action Research Arm Test
Time Frame: 12 weeks
The assessment were taken at baseline and after 12 weeks of intervention
12 weeks
Fugl-Meyer Assessment for Upper Extremity
Time Frame: 12 weeks
The assessment were taken at baseline and after 12 weeks of intervention
12 weeks
Modified Ashworth Scale
Time Frame: 12 weeks
The assessment were taken at baseline and after 12 weeks of intervention
12 weeks
grip strength via hand-held dynamometry
Time Frame: 12 weeks
The assessment were taken at baseline and after 12 weeks of intervention
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 3, 2025

Primary Completion (Actual)

January 3, 2026

Study Completion (Actual)

January 3, 2026

Study Registration Dates

First Submitted

June 27, 2026

First Submitted That Met QC Criteria

June 27, 2026

First Posted (Actual)

July 6, 2026

Study Record Updates

Last Update Posted (Actual)

July 6, 2026

Last Update Submitted That Met QC Criteria

June 27, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on mirror therapy

3
Subscribe